Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Mitoxantrone hydrochloride liposome|DRUG: Capecitabine|DRUG: Mitoxantrone hydrochloride liposome|DRUG: Capecitabine
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Collaborators: CSPC Ouyi Pharmaceutical Co., Ltd.